APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide CXO

Peptide CXO covers outsourced research, process development and manufacturing for peptide programmes, from research material and analytical work to clinical and commercial supply.

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peptide CXO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025195 pages

Choose your research edition.

Industry ResearchPeptide CXO Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide CXO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Peptide CXO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide CXO Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide CXO Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Peptide CXO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide CXO include Chinese Peptide Company, WuXi AppTec, Shenzhen JYMed Technology, ReaLi Tide Biological Technology, Jiangsu Sinopep-Allsino Biopharmaceutical, LONZA, Asymchem, GL Biochem and Chengdu Shengnuo Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peptide CXO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide CXO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide CXO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide CXO market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide CXO Segment by Company

Chinese Peptide Company

WuXi AppTec

Shenzhen JYMed Technology

ReaLi Tide Biological Technology

Jiangsu Sinopep-Allsino Biopharmaceutical

LONZA

Asymchem

GL Biochem

Chengdu Shengnuo Biotechnology

AmbioPharm

Polypeptide

Pepscan

JPT Peptide

Bicycle

Bachem

Peptide CXO Segment by Type

CRO

CMO/CDMO

Peptide CXO Segment by Application

Pharmaceutical Companies

Biotech Companies and Research Institutions

Peptide CXO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CXO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide CXO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CXO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide CXO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide CXO industry.

Chapter 3: Detailed analysis of Peptide CXO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide CXOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide CXO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CRO Table 3. Key Players of CMO/CDMO Table 4. Global Peptide CXO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Companies Table 6. Key Players of Biotech Companies and Research Institutions Table 7. Global Peptide CXO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Peptide CXO Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Peptide CXO Market Share by Region (2021-2026) Table 10. Global Peptide CXO Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Peptide CXO Market Share by Region (2027-2032) Table 12. Peptide CXO Industry Trends Table 13. Peptide CXO Industry Drivers Table 14. Peptide CXO Industry Opportunities and Challenges Table 15. Peptide CXO Industry Restraints Table 16. Global Peptide CXO Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Peptide CXO Revenue Market Share by Company (2021-2026) Table 18. Global Peptide CXO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Peptide CXO Key Company Head Office and Area Served Table 20. Global Peptide CXO Company, Product Type & Application Table 21. Global Peptide CXO Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Peptide CXO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Peptide CXO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Peptide CXO Revenue Market Share by Type (2021-2026) Table 28. Global Peptide CXO Revenue Market Share by Type (2027-2032) Table 29. Global Peptide CXO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Peptide CXO Revenue Market Share by Application (2021-2026) Table 33. Global Peptide CXO Revenue Market Share by Application (2027-2032) Table 34. Chinese Peptide Company Company Information Table 35. Chinese Peptide Company Business Overview Table 36. Chinese Peptide Company Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Chinese Peptide Company Peptide CXO Product Portfolio Table 38. Chinese Peptide Company Recent Development Table 39. WuXi AppTec Company Information Table 40. WuXi AppTec Business Overview Table 41. WuXi AppTec Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. WuXi AppTec Peptide CXO Product Portfolio Table 43. WuXi AppTec Recent Development Table 44. Shenzhen JYMed Technology Company Information Table 45. Shenzhen JYMed Technology Business Overview Table 46. Shenzhen JYMed Technology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Shenzhen JYMed Technology Peptide CXO Product Portfolio Table 48. Shenzhen JYMed Technology Recent Development Table 49. ReaLi Tide Biological Technology Company Information Table 50. ReaLi Tide Biological Technology Business Overview Table 51. ReaLi Tide Biological Technology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. ReaLi Tide Biological Technology Peptide CXO Product Portfolio Table 53. ReaLi Tide Biological Technology Recent Development Table 54. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information Table 55. Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview Table 56. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Product Portfolio Table 58. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development Table 59. LONZA Company Information Table 60. LONZA Business Overview Table 61. LONZA Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. LONZA Peptide CXO Product Portfolio Table 63. LONZA Recent Development Table 64. Asymchem Company Information Table 65. Asymchem Business Overview Table 66. Asymchem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Asymchem Peptide CXO Product Portfolio Table 68. Asymchem Recent Development Table 69. GL Biochem Company Information Table 70. GL Biochem Business Overview Table 71. GL Biochem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. GL Biochem Peptide CXO Product Portfolio Table 73. GL Biochem Recent Development Table 74. Chengdu Shengnuo Biotechnology Company Information Table 75. Chengdu Shengnuo Biotechnology Business Overview Table 76. Chengdu Shengnuo Biotechnology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Chengdu Shengnuo Biotechnology Peptide CXO Product Portfolio Table 78. Chengdu Shengnuo Biotechnology Recent Development Table 79. AmbioPharm Company Information Table 80. AmbioPharm Business Overview Table 81. AmbioPharm Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. AmbioPharm Peptide CXO Product Portfolio Table 83. AmbioPharm Recent Development Table 84. Polypeptide Company Information Table 85. Polypeptide Business Overview Table 86. Polypeptide Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Polypeptide Peptide CXO Product Portfolio Table 88. Polypeptide Recent Development Table 89. Pepscan Company Information Table 90. Pepscan Business Overview Table 91. Pepscan Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Pepscan Peptide CXO Product Portfolio Table 93. Pepscan Recent Development Table 94. JPT Peptide Company Information Table 95. JPT Peptide Business Overview Table 96. JPT Peptide Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. JPT Peptide Peptide CXO Product Portfolio Table 98. JPT Peptide Recent Development Table 99. Bicycle Company Information Table 100. Bicycle Business Overview Table 101. Bicycle Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Bicycle Peptide CXO Product Portfolio Table 103. Bicycle Recent Development Table 104. Bachem Company Information Table 105. Bachem Business Overview Table 106. Bachem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Bachem Peptide CXO Product Portfolio Table 108. Bachem Recent Development Table 109. North America Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 110. North America Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 111. North America Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 112. North America Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 113. North America Peptide CXO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Peptide CXO Market Size by Country (2021-2026) Table 115. North America Peptide CXO Market Size by Country (2027-2032) Table 116. Europe Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 117. Europe Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 118. Europe Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 119. Europe Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 120. Europe Peptide CXO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Peptide CXO Market Size by Country (2021-2026) Table 122. Europe Peptide CXO Market Size by Country (2027-2032) Table 123. China Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 124. China Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 125. China Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 126. China Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 128. Asia Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 129. Asia Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 130. Asia Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Peptide CXO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Peptide CXO Market Size by Country (2021-2026) Table 133. Asia Peptide CXO Market Size by Country (2027-2032) Table 134. South America, Middle East & Africa Peptide CXO Market Size by Type (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Peptide CXO Market Size by Type (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Peptide CXO Market Size by Application (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Peptide CXO Market Size by Application (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Peptide CXO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. South America, Middle East & Africa Peptide CXO Market Size by Country (2021-2026) Table 140. South America, Middle East & Africa Peptide CXO Market Size by Country (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Peptide CXO Product Image Figure 2. Global Peptide CXO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptide CXO Market Share by Type: 2025 VS 2032 Figure 4. CRO Image Figure 5. CMO/CDMO Image Figure 6. Global Peptide CXO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Peptide CXO Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutical Companies Image Figure 9. Biotech Companies and Research Institutions Image Figure 10. Global Peptide CXO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 12. Global Peptide CXO Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Peptide CXO Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Peptide CXO Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Peptide CXO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Peptide CXO Revenue Market Share by Type (2021-2032) Figure 19. Global Peptide CXO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Peptide CXO Revenue Market Share by Application (2021-2032) Figure 21. North America Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 22. North America Peptide CXO Market Share by Type (2021-2032) Figure 23. North America Peptide CXO Market Share by Application (2021-2032) Figure 24. North America Peptide CXO Market Share by Country (2021-2032) Figure 25. United States Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 26. Canada Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 28. Europe Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 29. Europe Peptide CXO Market Share by Type (2021-2032) Figure 30. Europe Peptide CXO Market Share by Application (2021-2032) Figure 31. Europe Peptide CXO Market Share by Country (2021-2032) Figure 32. Germany Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 33. France Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 35. Italy Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 36. Russia Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 38. China Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 39. China Peptide CXO Market Share by Type (2021-2032) Figure 40. China Peptide CXO Market Share by Application (2021-2032) Figure 41. Asia Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 42. Asia Peptide CXO Market Share by Type (2021-2032) Figure 43. Asia Peptide CXO Market Share by Application (2021-2032) Figure 44. Asia Peptide CXO Market Share by Country (2021-2032) Figure 45. Japan Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 49. India Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 50. Australia Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Peptide CXO Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Peptide CXO Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Peptide CXO Market Share by Country (2021-2032) Figure 55. Brazil Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 60. UAE Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 62. Chile Peptide CXO Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • CRO
  • CMO/CDMO
Applications
  • Pharmaceutical Companies
  • Biotech Companies and Research Institutions
Companies covered
  • Chinese Peptide Company
  • WuXi AppTec
  • Shenzhen JYMed Technology
  • ReaLi Tide Biological Technology
  • Jiangsu Sinopep-Allsino Biopharmaceutical
  • LONZA
  • Asymchem
  • GL Biochem
  • Chengdu Shengnuo Biotechnology
  • AmbioPharm
  • Polypeptide
  • Pepscan
  • JPT Peptide
  • Bicycle
  • Bachem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptide CXO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CRO
  5. 1.2.3 CMO/CDMO
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Peptide CXO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Companies
  9. 1.3.3 Biotech Companies and Research Institutions
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Peptide CXO Growth Trends by Region
  12. 1.5.1 Global Peptide CXO Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Peptide CXO Market Size by Region (2021-2026)
  14. 1.5.3 Peptide CXO Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Peptide CXO Market Dynamics
  1. 2.1 Peptide CXO Industry Trends
  2. 2.2 Peptide CXO Industry Drivers
  3. 2.3 Peptide CXO Industry Opportunities and Challenges
  4. 2.4 Peptide CXO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptide CXO Revenue by Company (2021-2026)
  2. 3.2 Global Peptide CXO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptide CXO Key Company Head office and Area Served
  4. 3.4 Global Peptide CXO Company, Product Type & Application
  5. 3.5 Global Peptide CXO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptide CXO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptide CXO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptide CXO Tier 1, Tier 2, and Tier 3
4 Peptide CXO Market by Type
  1. 4.1 Global Peptide CXO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptide CXO Market Size by Type (2021-2032)
  3. 4.3 Global Peptide CXO Market Size Share by Type (2021-2032)
5 Peptide CXO Market by Application
  1. 5.1 Global Peptide CXO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide CXO Market Size by Application (2021-2032)
  3. 5.3 Global Peptide CXO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Chinese Peptide Company
  2. 6.1.1 Chinese Peptide Company Company Information
  3. 6.1.2 Chinese Peptide Company Business Overview
  4. 6.1.3 Chinese Peptide Company Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Chinese Peptide Company Peptide CXO Product Portfolio
  6. 6.1.5 Chinese Peptide Company Recent Developments
  7. 6.2 WuXi AppTec
  8. 6.2.1 WuXi AppTec Company Information
  9. 6.2.2 WuXi AppTec Business Overview
  10. 6.2.3 WuXi AppTec Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 WuXi AppTec Peptide CXO Product Portfolio
  12. 6.2.5 WuXi AppTec Recent Developments
  13. 6.3 Shenzhen JYMed Technology
  14. 6.3.1 Shenzhen JYMed Technology Company Information
  15. 6.3.2 Shenzhen JYMed Technology Business Overview
  16. 6.3.3 Shenzhen JYMed Technology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shenzhen JYMed Technology Peptide CXO Product Portfolio
  18. 6.3.5 Shenzhen JYMed Technology Recent Developments
  19. 6.4 ReaLi Tide Biological Technology
  20. 6.4.1 ReaLi Tide Biological Technology Company Information
  21. 6.4.2 ReaLi Tide Biological Technology Business Overview
  22. 6.4.3 ReaLi Tide Biological Technology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ReaLi Tide Biological Technology Peptide CXO Product Portfolio
  24. 6.4.5 ReaLi Tide Biological Technology Recent Developments
  25. 6.5 Jiangsu Sinopep-Allsino Biopharmaceutical
  26. 6.5.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
  27. 6.5.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview
  28. 6.5.3 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Product Portfolio
  30. 6.5.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments
  31. 6.6 LONZA
  32. 6.6.1 LONZA Company Information
  33. 6.6.2 LONZA Business Overview
  34. 6.6.3 LONZA Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LONZA Peptide CXO Product Portfolio
  36. 6.6.5 LONZA Recent Developments
  37. 6.7 Asymchem
  38. 6.7.1 Asymchem Company Information
  39. 6.7.2 Asymchem Business Overview
  40. 6.7.3 Asymchem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Asymchem Peptide CXO Product Portfolio
  42. 6.7.5 Asymchem Recent Developments
  43. 6.8 GL Biochem
  44. 6.8.1 GL Biochem Company Information
  45. 6.8.2 GL Biochem Business Overview
  46. 6.8.3 GL Biochem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GL Biochem Peptide CXO Product Portfolio
  48. 6.8.5 GL Biochem Recent Developments
  49. 6.9 Chengdu Shengnuo Biotechnology
  50. 6.9.1 Chengdu Shengnuo Biotechnology Company Information
  51. 6.9.2 Chengdu Shengnuo Biotechnology Business Overview
  52. 6.9.3 Chengdu Shengnuo Biotechnology Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Chengdu Shengnuo Biotechnology Peptide CXO Product Portfolio
  54. 6.9.5 Chengdu Shengnuo Biotechnology Recent Developments
  55. 6.10 AmbioPharm
  56. 6.10.1 AmbioPharm Company Information
  57. 6.10.2 AmbioPharm Business Overview
  58. 6.10.3 AmbioPharm Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AmbioPharm Peptide CXO Product Portfolio
  60. 6.10.5 AmbioPharm Recent Developments
  61. 6.11 Polypeptide
  62. 6.11.1 Polypeptide Company Information
  63. 6.11.2 Polypeptide Business Overview
  64. 6.11.3 Polypeptide Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Polypeptide Peptide CXO Product Portfolio
  66. 6.11.5 Polypeptide Recent Developments
  67. 6.12 Pepscan
  68. 6.12.1 Pepscan Company Information
  69. 6.12.2 Pepscan Business Overview
  70. 6.12.3 Pepscan Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Pepscan Peptide CXO Product Portfolio
  72. 6.12.5 Pepscan Recent Developments
  73. 6.13 JPT Peptide
  74. 6.13.1 JPT Peptide Company Information
  75. 6.13.2 JPT Peptide Business Overview
  76. 6.13.3 JPT Peptide Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 JPT Peptide Peptide CXO Product Portfolio
  78. 6.13.5 JPT Peptide Recent Developments
  79. 6.14 Bicycle
  80. 6.14.1 Bicycle Company Information
  81. 6.14.2 Bicycle Business Overview
  82. 6.14.3 Bicycle Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Bicycle Peptide CXO Product Portfolio
  84. 6.14.5 Bicycle Recent Developments
  85. 6.15 Bachem
  86. 6.15.1 Bachem Company Information
  87. 6.15.2 Bachem Business Overview
  88. 6.15.3 Bachem Peptide CXO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Bachem Peptide CXO Product Portfolio
  90. 6.15.5 Bachem Recent Developments
7 North America
  1. 7.1 North America Peptide CXO Market Size (2021-2032)
  2. 7.2 North America Peptide CXO Market Size by Type
  3. 7.2.1 North America Peptide CXO Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptide CXO Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptide CXO Market Share by Type (2021-2032)
  6. 7.3 North America Peptide CXO Market Size by Application
  7. 7.3.1 North America Peptide CXO Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptide CXO Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptide CXO Market Share by Application (2021-2032)
  10. 7.4 North America Peptide CXO Market Size by Country
  11. 7.4.1 North America Peptide CXO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptide CXO Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptide CXO Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptide CXO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptide CXO Market Size (2021-2032)
  2. 8.2 Europe Peptide CXO Market Size by Type
  3. 8.2.1 Europe Peptide CXO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptide CXO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptide CXO Market Share by Type (2021-2032)
  6. 8.3 Europe Peptide CXO Market Size by Application
  7. 8.3.1 Europe Peptide CXO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptide CXO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptide CXO Market Share by Application (2021-2032)
  10. 8.4 Europe Peptide CXO Market Size by Country
  11. 8.4.1 Europe Peptide CXO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptide CXO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptide CXO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptide CXO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptide CXO Market Size (2021-2032)
  2. 9.2 China Peptide CXO Market Size by Type
  3. 9.2.1 China Peptide CXO Market Size by Type (2021-2026)
  4. 9.2.2 China Peptide CXO Market Size by Type (2027-2032)
  5. 9.2.3 China Peptide CXO Market Share by Type (2021-2032)
  6. 9.3 China Peptide CXO Market Size by Application
  7. 9.3.1 China Peptide CXO Market Size by Application (2021-2026)
  8. 9.3.2 China Peptide CXO Market Size by Application (2027-2032)
  9. 9.3.3 China Peptide CXO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptide CXO Market Size (2021-2032)
  2. 10.2 Asia Peptide CXO Market Size by Type
  3. 10.2.1 Asia Peptide CXO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptide CXO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptide CXO Market Share by Type (2021-2032)
  6. 10.3 Asia Peptide CXO Market Size by Application
  7. 10.3.1 Asia Peptide CXO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptide CXO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptide CXO Market Share by Application (2021-2032)
  10. 10.4 Asia Peptide CXO Market Size by Country
  11. 10.4.1 Asia Peptide CXO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptide CXO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptide CXO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptide CXO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptide CXO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptide CXO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptide CXO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptide CXO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptide CXO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptide CXO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptide CXO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptide CXO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptide CXO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptide CXO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptide CXO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptide CXO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptide CXO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptide CXO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst